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The  network  theory  of the  immune  system proposes  that  idiotype-anti-idiotype 
interactions provide important immunoregulatory controls (1). In many experimental 
systems, the passive administration of heterologous anti-idiotypic antibody has been 
shown  to  enhance  (2)  or suppress  (3)  immune responses.  In addition,  spontaneous 
auto-anti-idiotypic antibody has been detected after antigenic challenge (4), generally 
appearing  coincident  with  a  decline  in  antibody  titer  (5).  These  findings  have 
suggested that network controls might similarly regulate the formation of pathological 
autoantibodies  (6).  Two recent studies support  this hypothesis. In one, rabbit anti- 
(anti-thyroglobulin)  idiotype prevented spontaneous autoimmune thyroid disease in 
Buffalo rats  (7).  In the other,  anti-(anti-DNA)-idiotype was found  in  the serum of 
systemic lupus erythematosus (SLE) 1 patients when they were in remission (8). 
In  the  current  work, we have investigated  the  SLE  mouse strain  NZB  for anti- 
(autoantibody)-idiotypic antibodies that might play an immunoregulatory role. With 
age,  these  mice spontaneously  produce  IgG anti-erythrocyte  autoantibodies  which 
mediate a severe Coombs-positive hemolytic anemia (9). The Fa hybrids of NZB and 
several normal strains are known to develop a  milder hemolytic disease with lower 
levels of Coombs antibodies  (10). We have found that some of these hybrids sponta- 
neously produce high titers of anti-(anti-erythrocyte)-idiotype antibodies that specif- 
ically  recognize  the  NZB  Coombs  idiotypes.  This  finding  suggests  that  network 
idiotype-anti-idiotype control might play a protective role in suppressing autoantibody 
formation in these animals. 
Methods 
Mice.  NZB and CBA/J mice were obtained from The Jackson Laboratory, Bar Harbor, 
ME.  Some NZB mice used  in early experiments came from Southwestern  Medical  School, 
Dallas, TX. (NZB × CBA)F1 mice were bred in the animal facilities at the University of North 
Carolina. 
Mice were bled from the retro-orbital plexus.  To obtain erythrocyte (RBC)  suspensions, 
blood was pipetted  immediately into  a  large excess of Alsever's solution,  centrifuged,  and 
washed three times in saline before use. It was necessary to use fresh RBC for hemagglutination 
assays, as storage at 4°C overnight caused inconsistent results. Serum samples were obtained by 
* Supported by grant AM26574 from the National Institutes of Health, and by grants from the North 
Carolina Board of Science and Technology, the University of North Carolina Research Council, and the 
American Cancer Society. The authors are Senior Investigators  of the Anhrltis Foundation. 
1  Abbreviations used in this paper: BSA, bovine serum albumin; MRBC, mouse RBC; RBC, erythrocytes; 
SLE, systemic lupus erythematosus; SRBC, sheep RBC. 
J. ExP. MED. ©The Rockefeller  University Press • 0022-1007/82/07/0173/08 $1.00  173 
Volume 156  July  1982  173-180 174  ANTI-IDIOTYPES  IN  NZB  F1  MICE 
allowing blood to clot at room temperature and separating by centrifugation. Serum was stored 
in aliquots at -20°C before use. 
Hemagglutination Assays.  For direct Coombs assays,  washed  RBC from 9-10-too-old NZB 
mice were resuspended to  1% in normal saline containing 1% bovine serum albumin (BSA) 
(Sigmal Chemical Co., St. Louis, MO). For indirect hemagglutination  assays, a 10% suspension 
of washed normal mouse RBC (MRBC) from CBA mice was incubated with an equal volume 
of a  1:10 dilution of NZB serum for 30 rain at room temperature with rocking. In both assays, 
developing sera were diluted in BSA-normal saline in V-bottomed microtiter wells,  and an 
equal volume of I% RBC suspension was added. Hemagglutination was read after 1 h at room 
temperature. Titers represent the highest dilution giving _>2+ agglutination on a 0-4+ scale. 
The developing antiserum used for screening for Coombs positivity was rabbit anti-mouse 
IgG, which was raised by immunization with an IgG myeloma and rendered gamma-specific 
by absorption with insolubilized IgM and lambda and kappa light chains. Detection of anti- 
RBC autoantibodies of differing subclasses  was performed by using serial dilutions of rabbit 
antisera against mouse IgG1, IgG2a, IgG2b, and IgG3, all obtained from  Litton Bionetics 
(Kensington, MD) and found to be monospecific by gel diffusion. (NZB × CBA)F1 hybrid sera 
were used as developing reagents in anti-idiotype assays. 
Hemagglutination Inhibition Assays.  For confirmation of specificity, NZB sera were serially 
diluted and incubated for 30 min at room temperature with selected (CBA ×  NZB)FI sera at 
a concentration fourfold greater than the agglutination  endpoint. Appropriate Coombs-positive 
RBC were then added. After 60 rain at room temperature, the hemagglutination inhibition 
titer was read as the highest NZB serum dilution to completely inhibit agglutination. 
Absorptions.  Sepharose conjugates of monospecific goat anti-mouse IgG and of anti-trinitro- 
phenylated ovalbumin were kind gifts of Dr. Ellen Vitetta, University of Texas Health Science 
Center, Dallas, TX. Mouse IgG conjugated to Sepharose was provided by Dr. Stella Robinson 
(University of Texas  Health  Science Center).  MRBC  were coated  with  mouse IgG  (Miles 
Laboratories, Elkhart, IN), by the chromium chloride technique (11). IgG-coated sheep RBC 
(SRBC) were prepared by immunizing  CBA mice three times intraperitoneally  with 0.1 ml of 
10% SRBC at  10-d intervals, and incubating the resulting immune serum (which contained 
high titer IgG anti-SRBC antibody) with SRBC for 30 min at room temperature, followed by 
extensive washing. 
Preparation of Pepsin Fragments of Coombs and Anti-Idiotype Antibodies.  200 /11 of each of four 
NZB  indirect-Coombs-positive sera  and  four corresponding hybrid anti-idiotype sera  were 
precipitated with 45% saturated ammonium  sulfate. These partially-purified  IgG fractions were 
digested with  2%  pepsin at  37°C for  18  h  in 0.5M  acetate,  pH  4.5.  The resultant F(ab')~ 
fragments were absorbed with goat anti-mouse IgG (pFc'-specific)-Sepharose 4B. Absence of 
intact IgG and pFc' fragments was demonstrated in each case  by double immunodiffusion 
analysis. Fab' fragments were prepared from these F(ab')2 preparations by reduction with 0.01 
M dithiothreitol and alkylation with a  10% M excess of iodoacetamide. 
CBA RBC were coated with Fab and F(ab')z fragments of NZB IgG by incubating 10% 
washed CBA RBC with equal volume of a  1:20 dilution of these preparations (equivalent to a 
1:40 dilution of whole serum). Indirect hemagglutination  assays were done as described above. 
Results 
1;1 Sera Agglutinate  NZB E~ythrocytes.  We initially observed that  sera from certain 
(NZB ×  CBA)F1 mice agglutinated the RBC from some Coombs-positive NZB mice. 
RBC from Coombs-negative NZB mice were never agglutinated by any F1 sera. Sera 
from  NZB  mice  that  had  free-circulating anti-RBC  antibodies  (indirect  Coombs 
positive) could be used to coat normal MRBC so that they would be agglutinated by 
the same F1 sera that agglutinated the donor NZB RBC. The activity of the F1 sera 
was age related, as 0 of 47 6-8-wk-old (CBA ×  NZB)F1 sera were able to agglutinate, 
compared with 15 of 84 4-6-too-old sera. No difference was seen between F1 offspring 
of either CBA or NZB mothers. Agglutinating activity was not seen in the NZB or 
CBA parents, nor was it found in the unrelated mouse strains BALB/c and C57BL. PHILIP  L.  COHEN AND ROBERT A.  EISENBERG 
TABLE  I 
Absorption of (CBA  X  NZB)FI Serum 57 Agglutinating Activity 
Titer -1 vs. NZB  Titer -x vs. NZB  Absorbant  E1 RBC  C2 RBC 
None  12,800  6,400 
Sepharose-goat anti-mouse IgG  <10  <10 
Sepharose-goat anti-TNP-OVA*  6,400  6,400 
Sepharose-goat anti-KLH:~  12,800  3,200 
Mouse IgG-coated SRBC§  12,800  1,600 
Mouse IgG-eoated SRBCI]  25,600  6,400 
'* Trinitrophenylated ovalbumin. 
:~ Keyhole limpet hemocyanin. 
§ Coated with mouse anti-SRBC. 
][ Coated using CrCla. 
175 
TABLE  II 
Reactivity of (NZB X  CBA)FI Sera with NZB RBC (Reciprocal Titers) 
F1  NZB RBC 
serum  C1  C2  D2  E1  F1  F2  H1  H2  J1  J2  K1  K2 
42  51,200  3,200  --*  ....... 
45  1,280  --  1,280  ....... 
47  12,800  --  51,200  --  --  NT:]:  NT  NT  NT  NT 
54  102,400  2,560  --  51,200  2,560  1,280  --  --  NT  NT 
56  51,200  12,800  --  --  10,280 2,560  3,200  --  3,200  3,200 
57  12,800  51,200  --  12,800  200  --  --  NT  NT  NT 
63  640  --  320  --  --  --  NT  NT  NT  NT 
66  102,400" 51,200  2,560  51,200  --  --  NT  NT  NT  NT 
96  --  --  --  12,800  ...... 
143  --  --  1,600  .....  12,800  -- 
NT  NT 
NT  NT 
NT  NT 
NT  NT 
NT  NT 
* <50 
:]: Not tested. 
Nature of the F1 Agglutinating  Principle.  The  finding that  F1 sera would  agglutinate 
only Coombs-positive MRBC  suggested  that  an anti-antibody  might be involved. To 
test  this  hypothesis,  one  positive F1  serum  (serum  57)  was  absorbed  in  several  ways 
and  tested  against  RBC  from  two  Coombs-positive  NZB  mice  (El  and  C2).  As 
indicated  in Table  I, this particular combination  of sera and  cells gave high titers of 
agglutination. Absorption of the F1 serum with a column of anti-mouse IgG completely 
removed the agglutinating activity, whereas control columns had no significant effect. 
This suggested that  an antibody was responsible for the activity of the Fx serum.  One 
possibility  was  rheumatoid  factor;  however,  serum  57  failed  to  agglutinate  SRBC 
coated either with mouse anti-SRBC  antibody  or coated nonspecifically with normal 
mouse  IgG  (Table  I).  Mouse  IgG  bound  to  Sepharose  also  failed  to  remove  the 
agglutinating  activity from another  F1 serum  (not  shown).  Similar absorption  exper- 
iments with four other F1 sera gave comparable  results. 
Specificity of Agglutinating  Principle.  One  of the most striking features  of the agglu- 
tination phenomenon  was the specificity that individual Ft sera showed for individual 
NZB  RBC. A  summary  of titrations of 10 reacting F1 sera with RBC  from each of 12 
Coombs-positive NZB  mice is shown  in Table  II. Although  certain  sera  and  certain 176  ANTI-IDIOTYPES  IN  NZB  F1  MICE 
TABLE  III 
Lack of Correlation Between Coombs Antibody Subclass and Agglutination by Ft Serum 
Serum 
NZB RBC 
AI  B1  B4  C1  C2  C4  D2  D3  F3  G1  G4 
Rabbit anti-IgG  +  +  +  +  +  +  +  +  +  +  + 
Rabbit anti-IgG 1  +  -  -  +  +  +  +  +  -  -  + 
Rabbit anti-IgG2a  +  +  -  +  +  +  +  +  +  -  - 
Rabbit anti-IgG2b  -  +  +  +  +  +  +  +  -  +  - 
Rabbit anti-lgG3  -  -  -  +  +  +  +  +  +  -  - 
Fl serum 56  -  -  -  +  +  -  -  +  -  -  + 
F~ serum  143  ......  +  --  +  --  - 
TABLE  IV 
Agglutination Inhibition by NZB Sera 
Reciprocal hemagglutina- 
Inhibiting serum  tion-inhibition titer 
Serum 96 vs. E1  RBC 
C1  --* 
C2 
D2 
El  80 
FI 
HI 
J1 
Mouse IgG (1 mg/ml) 
Serum 143 vs. Jl  RBC 
C1 
C2 
D2  80 
E1 
F1 
H1 
JX  320 
Mouse IgG (1 mg/ml) 
*  <10. 
cells were more reactive than others, the overall pattern suggested individual specific- 
ities of a  qualitative nature.  For example, F1 serum 42  agglutinated RBC  C1  with a 
titer of 51,200, but failed to agglutinate erythrocytes J  1. Conversely, serum  143 failed 
to  agglutinate NZB  RBC  C1  but  agglutinated  RBC  J1  with  a  titer of 12,800.  It  is 
unlikely  that  this  individual  specificity represented the  reactivity of F1  rheumatoid 
factors with selected subclasses of mouse IgG, as we found no obvious correlation of 
the pattern of reactivity of NZB erythrocytes with heterologous anti-subclass antisera 
compared  with the pattern of reactivity with the (CBA ×  NZB)F1 sera (Table III). 
The individual specificity of the reactivities was confirmed by blocking experiments, 
as shown in Table IV. The  reactivity ofF1 serum 96 vs. NZB  E1  RBC  (see Table  II) 
could be inhibited by serum from mouse E1  but not by serum from six other Coombs- 
positive  NZB  mice,  the  RBC  of which  did  not  react  with  F1  serum  96.  Similarly, PHILIP L. COHEN AND ROBERT A.  EISENBERG  177 
TABLE g 
Agglutination of Autoantibody-coated RBC by Whole or Pepsin-digested (NZB  X  CBA)F1 Sera 
Uncoated 
F~  Reagent  MRBC 
Normal MRBC  coated  with NZB  Normal MRBC  coated  with  NZB 
whole sera  F(ab')2 
NZB-5  NZB-12  NZB-22  NZB-25  NZB-5  NZB-12  NZB-22  NZB-25 
Mouse  2-5 whole serum*  -  +  -  +  -  +  -  + 
Mouse  2-5 F(ab')2  -  -  +  -  +  -  +  -  + 
Mouse  3-1  whole serum  -  +  -  -  -  +  -  -- 
Mouse  3-1  F(ab%  .....  +  -  - 
Mouse  4-3 whole serum  -  +  -  +  -  +  +  +  - 
Mouse  4-3 F(ab')2  -  +  +  +  -  +  +  +  - 
Mouse  4-4 whole serum  -  +  +  +  -  +  +  -  - 
Mouse  4-4 F(ab')2  --  +  -  -  +  +  -  - 
Anti  K  +  anti ~  -  +  +  +  +  +  +  -  + 
Buffer  ........ 
*  1:20 dilution. 
:~ Mixture of 1:50  dilution of rnonospecific goat anti-mouse x and goat anti-mouse A sera 
TABLE VI 
Comparison of F(ab ')2 and Fab ' Agglutination of F(ab ')2 and Fab '-coated Mouse RBC 
Agglutinating  FI  mouse 
fragment 
F(ab')2  coating reagent  tab' coating ruagen 
Saline  NZB-5  NZB-12  NZB-22  NZB-25  NZB-5  NZB-12  NZB-22  NZB-25 
F(ab')2* 
Fab':~ 
Anti r  +  anti ~§ 
2-5  --  +  --  +  .... 
3-I  --  +  ...... 
4-3  --  +  +  +  ..... 
4-4  --  +  +  +  ..... 
2-5  ........ 
3-1  ........ 
4-3  ........ 
4-4  --  +/  ........ 
--  +  +  +  +  +  +  +  + 
*  1:20  dilution. 
l: 10 dilution. 
§ 1:50  dilution. 
serum  143 could be inhibited in its reactions with NZB J1 RBC by J1 serum, and also 
by serum from another NZB with which  143 reacted,  D2. Thus, the individual NZB 
specificities  seen by the F1 sera were represented consistently both on the NZB  RBC 
and in their serum. 
Agglutination  Required Fab'-Anti-Fab'  Binding.  If the agglutinating phenomenon we 
observed was due to idiotype-anti-idiotype interactions, the binding function of both 
the Fx serum and the NZB Coombs antibody should be contained in the Fob portion 
of IgG. To demonstrate this, 45% ammonium sulphate fractions of four individual F1 
sera and four NZB sera containing antibodies that reacted with at least some of the 
chosen F1 sera were all digested with pepsin and carefully purified free of intact IgG 
(see Methods). Due to the small volume involved, the resultant reagents could only be 
tested at a single dilution. The patterns of reactivity of the F1 F(ab')2 fragments were 
in general no different  than those of the  initial F1 sera (Table V). In addition, the F1 
serum [or F(ab')z] equally agglutinated  normal MRBC  coated with either NZB sera 
or with  the  F(ab')2  fragments  purified  from  these sera  (Table  V).  Furthermore,  as 
shown in Table  VI,  reduction and alkylation  of the FI  F(ab')2,  completely removed 
their  agglutinating  activities.  Finally,  normal  MRBC  coated  with  reduced  and 
alkylated  NZB  F(ab')2  (i.e.,  Fab')  were  not agglutinated  with  F1  F(ab')2  fragments, 178  ANTI-IDIOTYPES  IN  NZB  Fx  MICE 
but still could be agglutinated with heterologous antibodies to mouse light chains 
(Table VI). 
Discussion 
The  present  data  indicate  that  certain  NZB  F1  hybrids spontaneously produce 
antibodies directed against idiotypes of NZB Coombs anti-RBC antibodies. Evidence 
for the idiotype specificity of these antibodies derives from: (a) the selective reactivity 
of certain F1 sera with only certain NZB RBC (Table II); (b) the inhibition of F1 sera- 
NZB  RBC  agglutination  by  only  those  NZB  sera  from  mice  whose  RBC  were 
recognized  by  the  F1  sera  (Table  IV);  (c)  the  fact  that  F1  (F(ab')2  fragments 
agglutinated RBC  coated with  F(ab')2  fragments of the  Coombs antibody, which 
indicated that Fab-Fab interactions were sufficient (Table V); and (d) the failure of 
F1 sera to agglutinate MRBC coated with NZB Fab', which indicated that the FI sera 
recognized determinants near the antigen-binding site of the Coombs antibody. That 
the observed agglutination might be due to rheumatoid factor was ruled out by the 
patterns of serum reactivity, the failure to absorb out activity with mouse IgG in a 
variety of forms, and the specificity for the F(ab')2 portion of the Coombs antibody 
molecule. In sum, then, all our data are consistent with the interpretation that the F~- 
agglutinating activity is an anti-(anti-RBC)-idiotypic antibody. An unlikely alterna- 
tive explanation would be that the F~ sera recognize V-region subgroups (12).  This 
possibility cannot be formally excluded, because it has been shown that such markers 
on  anti-Rh  antibodies can  be  blocked  by antigen  binding  (13,  14). However, we 
believe  it  improbable  that  such  anti-V-region  subgroup  antibodies would sponta- 
neously arise in the F~, and that they would show the high degree of specificity for 
individual NZB Coombs antibodies (Tables II and IV). 
The observation of anti-idiotypic antibody to an autoantibody is in keeping with 
several experimental reports  (15-17)  of the formation of spontaneous anti-idiotype 
antibody against previously synthesized antibody directed against exogenous antigens. 
(NZB X CBA)F1 mice and other NZB hybrids develop hemolytic disease less severe 
than  that  of their  NZB  parent  (I0).  Furthermore,  it  has  been  reported  that  the 
Coombs  antibody  found  in  certain  NZB  hybrid  mice  is  allotype  restricted  and 
therefore probably oligoclonal (18). The small amount and clonal restriction of NZB 
hybrid anti-RBC autoantibody may be the result of anti-idiotypic regulation (albeit 
imperfect) of these self-reactive specificities. It is of interest that we have not detected 
anti-idiotypic antibody against Coombs antibody either in NZB mice or in normal 
strains. 
That a hemagglutination assay is capable of detecting anti-(anti-Coombs) idiotypic 
antibody may reveal something of the nature of the Coombs antibody. It is likely that 
one of the two Fab regions of the Coombs antibody must be relatively free for the 
anti-idiotypic antibody to recognize it. The fact that (anti-RBC)Fab'-coated MRBC 
can be agglutinated by anti-light chain antisera, but not by F1 anti-idiotype sera is in 
accord with this interpretation. Such a  mechanism argues for substantial univalent 
attachment of the Coombs antibody to the RBC surface, a hypothesis consistent with 
low avidity and the presence of free antibody in the serum. It also implies that the 
epitopes recognized by the Coombs antibody are  widely spaced  on  RBC.  Similar 
conclusions were reached in studies of the reactivity of idiotypic, V-region framework, PHILIP L.  COHEN AND ROBERT  A.  EISENBERG  179 
and constant-region antisera with RBC coated with F(ab')2 or Fab' fragments of anti- 
Rh antibodies (13,  14). 
The data thus far collected allow only a rough estimation of the size of the repertoire 
of the NZB Coombs antibody. Cross-reactivity using anti-idiotype containing Fa sera 
suggests several shared idiotypes; however, the complex pattern of reactivity (Table 
II) implies more than one anti-idiotypic specificity in some Fa sera and more than one 
Coombs idiotype on some NZB RBC. It will be important to quantitate anti-idiotypic 
antibody  and  Coombs  antibody  levels over time  in  individual  mice to  define  the 
relationship between RBC autoantibody levels and the appearance of anti-idiotype. 
With the availability of anti-idiotypic reagents to the NZB Coombs antibody, direct 
functional  studies  will  also  be  possible  to  elucidate  the  role  of such  antibodies  in 
regulation of autoantibody levels and autoimmune disease. 
Summary 
The Fa hybrids of NZB and several normal mouse strains are known to produce less 
anti-erythrocyte  (Coombs)  autoantibody  and  develop  a  milder  hemolytic  anemia 
than their NZB parents. We have found that serum from some (NZB ×  CBA)F1 mice 
agglutinated erythrocytes from certain Coombs-positive NZB mice, often in extremely 
high  titer,  whereas  other  (CBA  X  NZB)F1  sera  agglutinated  erythrocytes  from 
different individual NZB mice. The agglutination was due to antibody, but was not 
due to rheumatoid factor activity. Because F(ab')~ fragments of the F1 sera agglutin- 
ated  erythrocytes coated  with  F(ab')2 fragments of the  appropriate  NZB  sera,  the 
observed  reactivity  was  probably caused  by  idiotype-anti-idiotype  interactions.  In 
addition,  because  F1  sera  could  not  agglutinate  mouse  erythrocytes  coated  with 
monovalent  NZB  Fab'  fragments,  the  recognized  idiotype  probably  involved  the 
antigen-binding site. Anti-idiotypic antibodies against anti-erythrocyte autoantibodies 
may play an important role in the regulation of autoantibody formation. 
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